<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01844258</url>
  </required_header>
  <id_info>
    <org_study_id>CCPMOH2010-China3</org_study_id>
    <nct_id>NCT01844258</nct_id>
  </id_info>
  <brief_title>Modified Surgical Techniques for Pediatric Cataract Treatment</brief_title>
  <official_title>Modified Surgical Techniques for Pediatric Cataract Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pediatric cataract is totally different from adult cataract. There is traditionally no
      difference in technique between pediatric and adult cataract surgery. Opacification of the
      visual axis was the most frequent complication after pediatric surgery. In this clinical
      study, the investigators aimed to evaluate the safety and postoperative recovery of a
      modified technique for pediatric cataract surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a randomized, controlled clinical trial with the following objectives:

        -  To determine whether infants with congenital cataract have improved visual outcomes
           following cataract extraction surgery using (1) the traditional capsulorhexis method or
           (2) our new minimally invasive method.

        -  To determine the occurrence of postoperative complications among infants with congenital
           cataract following cataract extraction surgery using (1) the traditional capsulorhexis
           method or (2) our new minimally invasive method.

      The study is conducted for the following reasons:

        -  Transplantation of pluripotent stem cells represents an appealing therapeutic strategy
           in regenerative medicine, but its clinical applications have been hindered in part by
           concerns about tumorigenicity and immune rejection. The use of endogenous stem cells
           provides a possible solution to this problem.

        -  Lens regeneration has been reported in lower vertebrate animals. Furthermore, residual
           endogenous lens epithelial stem cells (LESCs) after lens removal in rabbits have been
           shown to proliferate and generate lens fibers.

        -  Cataract, or opacification of the lens, is a major cause of blindness worldwide. Surgery
           for congenital cataract carries a significant risk of complications and often requires
           additional surgical procedures to maintain the transparency of the visual axis.

        -  Implantation of intraocular lenses (IOLs) following cataract extraction is becoming
           increasingly common in the pediatric population. However, their use is controversial in
           children younger than two years old (especially not recommended in children younger than
           6 months old due to the high incidences of IOL-related complications), as the refractive
           power of the eye continues to develop. In addition, IOLs have many limitations,
           including dislocation, less than ideal biocompatibility, inadequate accommodative
           properties, and suboptimal visual outcomes.

        -  The trial will demonstrate whether a modified cataract surgical technique can regenerate
           the lens from endogenous stem cells. It will also compare the incidence of complications
           and characterize visual outcomes in pediatric patients treated with the modified
           surgical technique versus the traditional surgical technique.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of opacification of the visual axis</measure>
    <time_frame>six months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual function in eyes treated for cataract</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Postoperative complications</measure>
    <time_frame>6 months</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">37</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Modified technique for I/A group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In the modified cataract surgery procedure, the size of the capsulorhexis opening will be decreased to 1.0-1.5 mm in diameter.
The capsulorhexis will be located in the peripheral area of the lens instead of the central area.
A 0.9 mm phacoemulsification probe will be used to remove the cataractous lens.
One drop of 0.5% or 1% atropine and an antibiotic/steroid ointment will be placed in the eye, which will then be patched.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Traditional technique for I/A group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>• In traditional technique group, the cataractous lens will be removed through an anterior continuous curvilinear capsulorhexis (ACCC) that is about 5-6 mm in diameter.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Modified technique</intervention_name>
    <description>Peripheral 1-1.5 mm curvilinear capsulorhexis of anterior capsule</description>
    <arm_group_label>Modified technique for I/A group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Traditional technique</intervention_name>
    <description>Central 5-6 mm curvilinear capsulorhexis of anterior capsule</description>
    <arm_group_label>Traditional technique for I/A group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 1 month and 24 months

          -  Uncomplicated congenital cataract (≥ 3 mm central dense opacity) in one or both eyes
             with an intact non-fibrotic capsular bag

          -  Informed consent signed by a parent or legal guardian

        Exclusion Criteria:

          -  Intraocular pressure &gt;21 mmHg

          -  Preterm birth (&lt;28 weeks)

          -  Presence of other ocular diseases (keratitis, keratoleukoma, aniridia, glaucoma) or
             systemic disease (congenital heart disease, ischemic encephalopathy)

          -  History of ocular diseases (any congenital eye diseases, such as, congenital cataract,
             congenital glaucoma, congenital aniridia) in the family

          -  History of ocular trauma

          -  Microcornea

          -  Persistent hyperplastic primary vitreous

          -  Rubella

          -  Lowe syndrome
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>24 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yizhi Liu, Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Zhongshan Ophthalmic Center, Sun Yat-sen University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Zhongshan Ophthalmic Center,Sun Yat-sen U</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510060</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://www.gzzoc.com</url>
    <description>Home page for Zhongshan Ophthalmic Center</description>
  </link>
  <link>
    <url>http://www.cnccclub.com</url>
    <description>Website for children cataract home</description>
  </link>
  <reference>
    <citation>Wilson ME Jr, Hafez GA, Trivedi RH. Secondary in-the-bag intraocular lens implantation in children who have been aphakic since early infancy. J AAPOS. 2011 Apr;15(2):162-6. doi: 10.1016/j.jaapos.2010.12.008. Epub 2011 Apr 3.</citation>
    <PMID>21463960</PMID>
  </reference>
  <reference>
    <citation>Grewal DS, Basti S. Modified technique for removal of Soemmerring ring and in-the-bag secondary intraocular lens placement in aphakic eyes. J Cataract Refract Surg. 2012 May;38(5):739-42. doi: 10.1016/j.jcrs.2012.02.023.</citation>
    <PMID>22520301</PMID>
  </reference>
  <reference>
    <citation>Shrestha UD. Cataract surgery in children: controversies and practices. Nepal J Ophthalmol. 2012 Jan-Jun;4(1):138-49. doi: 10.3126/nepjoph.v4i1.5866. Review.</citation>
    <PMID>22344012</PMID>
  </reference>
  <reference>
    <citation>Tassignon MJ, Gobin L, Mathysen D, Van Looveren J, De Groot V. Clinical outcomes of cataract surgery after bag-in-the-lens intraocular lens implantation following ISO standard 11979-7:2006. J Cataract Refract Surg. 2011 Dec;37(12):2120-9. doi: 10.1016/j.jcrs.2011.06.025.</citation>
    <PMID>22108108</PMID>
  </reference>
  <reference>
    <citation>Amon M. Surgical management challenges and clinical results of bimanual micro-incision phacoemulsification cataract surgery in children with congenital cataract. Nepal J Ophthalmol. 2011 Jan-Jun;3(1):3-8. doi: 10.3126/nepjoph.v3i1.4270.</citation>
    <PMID>21505539</PMID>
  </reference>
  <reference>
    <citation>Nihalani BR, VanderVeen DK. Technological advances in pediatric cataract surgery. Semin Ophthalmol. 2010 Sep-Nov;25(5-6):271-4. doi: 10.3109/08820538.2010.518836. Review.</citation>
    <PMID>21091011</PMID>
  </reference>
  <reference>
    <citation>Lin H, Chen W, Luo L, Congdon N, Zhang X, Zhong X, Liu Z, Chen W, Wu C, Zheng D, Deng D, Ye S, Lin Z, Zou X, Liu Y. Effectiveness of a short message reminder in increasing compliance with pediatric cataract treatment: a randomized trial. Ophthalmology. 2012 Dec;119(12):2463-70. doi: 10.1016/j.ophtha.2012.06.046. Epub 2012 Aug 24.</citation>
    <PMID>22921386</PMID>
  </reference>
  <reference>
    <citation>Luo L, Lin H, Chen W, Wang C, Zhang X, Tang X, Liu J, Congdon N, Chen J, Lin Z, Liu Y. In-the-bag intraocular lens placement via secondary capsulorhexis with radiofrequency diathermy in pediatric aphakic eyes. PLoS One. 2013 Apr 24;8(4):e62381. doi: 10.1371/journal.pone.0062381. Print 2013.</citation>
    <PMID>23638058</PMID>
  </reference>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 28, 2013</study_first_submitted>
  <study_first_submitted_qc>April 30, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 1, 2013</study_first_posted>
  <last_update_submitted>December 21, 2015</last_update_submitted>
  <last_update_submitted_qc>December 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Haotian Lin</investigator_full_name>
    <investigator_title>Ophthalmologist</investigator_title>
  </responsible_party>
  <keyword>pediatric cataract</keyword>
  <keyword>lens regeneration</keyword>
  <keyword>endogenous lens epithelial stem cells</keyword>
  <keyword>visual axis opacification</keyword>
  <keyword>visual function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

